Monitoring Neural Tissues Properties by Modulated Imaging (MI) (MI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00555711|
Recruitment Status : Withdrawn (no subject)
First Posted : November 9, 2007
Last Update Posted : February 10, 2017
We have developed a safe, non-contact, intra-operative guidance system to optimize tumor resection in neurosurgery. The Modulated Imaging is non-contact optical imaging technology developed at the Beckman Laser Institute, UCI.
Compared to other imaging approaches, MI has the unique capability of performing both diffuse optical tomography and rapid, wide-field quantitative mapping of tissue optical properties within a single measurement platform.
Preliminary in vivo studies have shown that brain tumors, infiltrating tumor margins and normal brain may have intrinsically different optical properties.
|Condition or disease||Intervention/treatment|
|Brain Tumor||Device: Modulated Imaging|
While compatible with time-modulation methods, MI alternatively uses spatially-modulated illumination for imaging of tissue constituents.
The Modulated Imaging system consists of
- a light projection system that illuminates the tissue with spatial sinusoid patterns.
- a CCD camera which collects the diffusely reflected light in a non-contact geometry. The wavelength of illumination can be selected by bandpass filtering of a broadband source,or by use of a monochromatic source.
Lastly, tissue fluorescence measurements can be performed by placing a combination of source-blocking and bandpass emission filters in front of the camera.
The diffusely reflected amplitude of the modulated wave carries both optical property (absorption, fluorescence, scattering) and depth information. Specifically, the sampling depth of the spatially-modulated wave is a function of the frequency of illumination and the tissue optical properties.
During neurosurgery when nervous tissue is exposed by the attending neurosurgeon, intraoperative pictures will be taken using the modulated imager by the investigators.
The imaging procedure may delay completion of the surgical case by an estimated 10 to 20 minutes. This is minimal prolongation considering most brain tumor resections take several hours.
The images acquired will be processed after the surgical procedure and will not be available to the surgeon during the operative procedure.
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Monitoring Neural Tissues Properties by Modulated Imaging (MI)|
|Study Start Date :||November 2008|
|Estimated Primary Completion Date :||January 2012|
|Estimated Study Completion Date :||January 2012|
Device: Modulated Imaging
- Brain Tissue Property [ Time Frame: 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00555711
|United States, California|
|Beckman Laser Institute,University of California,Irvine|
|Irvine, California, United States, 92612|
|Neurosurgery department,University of California,Irvine|
|Orange, California, United States, 92868|
|Principal Investigator:||Mark Linskey, MD||University of California, Irvine|
|Principal Investigator:||Bruce J Tromberg, PhD||Beckman Laser Institute University of California Irvine|